Generalized morphea successfully treated with extracorporeal photochemotherapy (ECP)

Area of Science:

• Dermatology
• Immunology
• Photomedicine

Background:

• Morphea is a rare autoimmune connective tissue disease.
• Generalized morphea affects large areas of the skin and can lead to significant morbidity.
• Limited treatment options exist for severe or generalized morphea.

Observation:

• A single patient presented with severe generalized morphea.
• The patient underwent a combination treatment regimen.
• The treatment involved extracorporeal photopheresis (ECP) and broad-band ultraviolet A (UVA) therapy.

Findings:

• The patient experienced complete resolution of generalized morphea.
• The combination therapy was well-tolerated.
• Sclerotic lesions and associated symptoms fully subsided.

Implications:

• Extracorporeal photopheresis and UVA therapy show promise as a combined treatment for generalized morphea.
• This therapeutic approach may offer a new option for patients with treatment-resistant or severe morphea.
• Further research is warranted to confirm efficacy and safety in a larger cohort.